156 related articles for article (PubMed ID: 19672768)
1. The role of toll-like receptors in chronic B-cell malignancies.
Muzio M; Bertilaccio MT; Simonetti G; Frenquelli M; Caligaris-Cappio F
Leuk Lymphoma; 2009 Oct; 50(10):1573-80. PubMed ID: 19672768
[TBL] [Abstract][Full Text] [Related]
2. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models.
Bertilaccio MT; Simonetti G; Dagklis A; Rocchi M; Rodriguez TV; Apollonio B; Mantovani A; Ponzoni M; Ghia P; Garlanda C; Caligaris-Cappio F; Muzio M
Blood; 2011 Jul; 118(3):660-9. PubMed ID: 21652674
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors in lymphoid malignancies: double-edged sword.
Harsini S; Beigy M; Akhavan-Sabbagh M; Rezaei N
Crit Rev Oncol Hematol; 2014 Feb; 89(2):262-83. PubMed ID: 24051205
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors--sentries in the B-cell response.
Bekeredjian-Ding I; Jego G
Immunology; 2009 Nov; 128(3):311-23. PubMed ID: 20067531
[TBL] [Abstract][Full Text] [Related]
6. [Expression and function of toll-like receptors in B lymphocytes].
Liu HZ; Yang HZ; Hu ZW
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
[TBL] [Abstract][Full Text] [Related]
7. Control of B-cell responses by Toll-like receptors.
Pasare C; Medzhitov R
Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
10. Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy.
Mikulandra M; Pavelic J; Glavan TM
Curr Med Chem; 2017; 24(19):2011-2032. PubMed ID: 28322156
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
Salaun B; Romero P; Lebecque S
Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
Gavin AL; Hoebe K; Duong B; Ota T; Martin C; Beutler B; Nemazee D
Science; 2006 Dec; 314(5807):1936-8. PubMed ID: 17185603
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors and innate immunity.
Kumar H; Kawai T; Akira S
Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of Toll-like receptor signals in innate immune defence.
Trinchieri G; Sher A
Nat Rev Immunol; 2007 Mar; 7(3):179-90. PubMed ID: 17318230
[TBL] [Abstract][Full Text] [Related]
15. Toll or toll-free adjuvant path toward the optimal vaccine development.
Ishii KJ; Akira S
J Clin Immunol; 2007 Jul; 27(4):363-71. PubMed ID: 17370119
[TBL] [Abstract][Full Text] [Related]
16. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
Kabelitz D
Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory properties of Toll-like receptor ligands in chickens.
St Paul M; Brisbin JT; Abdul-Careem MF; Sharif S
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):191-9. PubMed ID: 23305711
[TBL] [Abstract][Full Text] [Related]
18. The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma.
Abdi J; Engels F; Garssen J; Redegeld F
Crit Rev Oncol Hematol; 2011 Nov; 80(2):225-40. PubMed ID: 21236697
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]